Th1 vaccination priming for active immunotheraphy

作者： Michael Har-Noy

DOI:

关键词:

摘要: The present invention includes vaccine compositions and methods for using these in active immunotherapy. include allogeneic activated Th1 memory cells. can also one or more disease-related antigens. administering the to provide a footprint normal individuals patients susceptible disease having minimal residual disease.

freepatentsonline.com 本地加速

google.com 本地加速

freepatentsonline.com LINK 下载加速

freepatentsonline.com UNKNOWN 下载加速

lens.org UNKNOWN 下载加速

参考文章(24)

Michael W. Graner, Yi Zeng, Hanping Feng, Emmanuel Katsanis, Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers. Cancer Immunology, Immunotherapy. ,vol. 52, pp. 226- 234 ,(2003) , 10.1007/S00262-002-0359-2

Richard L. Boyd, Stimulation of thymus for vaccination development ,(2001)

Michael Har-Noy, Methods for preparing t-cells for cell therapy ,(2005)

Michael Har-Noy, T-cell therapy formulation ,(2005)

Dennis M. White, Method and apparatus for fitting chain jewelry assembly on an individual ,(2005)

Michael Har-Noy, Cell therapy formulation method and composition ,(2005)

Michael Har-Noy, Allogeneic cell therapy: mirror effect ,(2004)

Michael L. Gruenberg, Surendra Chavan, Th1 CELL ADOPTIVE IMMUNOTHERAPY ,(2002)

Tsuneya Ohno, Preparation and administration of hybrid cell vaccines for the prevention of cancer ,(2003)

Surendra Sharma, Michael A. O'donnell, Helena R. Chang, Maureen A. Chung, Recombinant bcg vaccines for the prevention and treatment of cancer ,(2001)